VARKI PAUL
SEC CIK 1677896 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | CLO | 32.6K | — | $1.51M | 5 | 2025-12-10 | 2026-06-10 |
Most active insiders at AVTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sullivan Christopher Ryan | CFO | — | $3.72M |
| 2 | Doyle Mittie | Chief Medical Off | — | $2.98M |
| 3 | VARKI PAUL | CLO | — | $1.51M |
| 4 | Goldman Jonathan | Dir | — | $163.0K |
| 5 | Chan Mitchell | Dir | — | $72.5K |
| 6 | Riley Jennifer | Chief Strategy Off | — | $52.0K |
| 7 | Truex Samantha | Dir | — | — |
| 8 | KANTOFF AARON | Dir | — | — |
| 9 | NEIL GARRY ARTHUR | CEO, Dir | — | — |
| 10 | KAPLAN GILLA | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-12 16:41 | 2026-06-10 | AVTX | Avalo Therapeutics, Inc. | VARKI PAUL | CLO | F - Tax | $13.10 | -1,081 | 32.6K | -3% | -$14.2K | |
| 2026-05-26 16:10 | 2026-05-21 | AVTX | Avalo Therapeutics, Inc. | VARKI PAUL | CLO | A - Grant | $0.00 | +24.3K | 27.9K | +669% | $0 | |
| DMT | 2026-05-07 16:18 | 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | VARKI PAUL | CLO | M - OptEx | $12.53 | +75.1K | 78.7K | +2,066% | +$940.4K |
| DMT | 2026-05-07 16:18 | 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | VARKI PAUL | CLO | S - Sale+OE | $20.17 | -75.1K | 3,634 | -95% | -$1.51M |
| 2025-12-12 | 2025-12-10 | AVTX | Avalo Therapeutics, Inc. | VARKI PAUL | CLO | F - Tax | $4.10 | -1,016 | 3,634 | -22% | -$4,166 |
Purchase Sale Sale after option exercise All abbreviations